InvestorsHub Logo
Followers 40
Posts 866
Boards Moderated 0
Alias Born 01/13/2011

Re: misiu143 post# 207800

Friday, 04/29/2022 11:18:10 AM

Friday, April 29, 2022 11:18:10 AM

Post# of 232889
Hi Misiu, it does make one think about what the portfolios of those who are short CYDY might look like, particularly with respect to where they might be long, e.g. merc, pfizer, j&j, etc.

These companies stand to lose SIGNIFICANT money when Leronlimab, and all of its indications, begin generating SIGNIFICANT revenue, thus diverting said SIGNIFICANT revenue away from those large biotech behemoths and all of their shareholders. The demand will be immense when the world begins to learn about the efficacy and safety profile of Leronlimab. In fact, I get the impression that the world is just beginning to take notice and that it's only a matter of time before their attention becomes much more focused and directed at the viability and safety of Leronlimab. Too much valuable information is beginning to make its way to mainstream media, e.g. Fox, for example.

It occurs to me that being long CYDY, is much like holding short positions on those behemoth biotech companies but without the risk. I can't even begin to imagine how the shorts must be feeling knowing what all they know about CYDY. I'm so glad my money is safely, IMO, invested with CYDY. My opinion is that the rewards for doing so will be extremely lucrative.

Hang in there Misiu and thanks for your dedication and valuable support.

All IMHO

"Falsus in unum, falsus in omnibus" / “Lie about one thing, lie about it all”

"The greatest obstacle to discovering the shape of the earth, the continents, and the oceans was not ignorance, but the illusion of knowledge" -Daniel J. Boorstin

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News